SOFINNOVA VENTURE PARTNERS VII L P
CIK 1380734 · last filed 2012-01-17
SOFINNOVA VENTURE PARTNERS VII L P is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2010. The most recent filing, for TSRX, was dated Jan 17, 2012. Across all open-market trades the lifetime net is −$2.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8.21M
2
4
-$2.36M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Trius Therapeutics Inc (TSRX) Delisted | 10%+ Owner | 144,622 | — | — | $20.75M | 3 | 2012-01-17 |
| AMRN | 10%+ Owner | 605,984 | $13.55 | $8.21M | -$23.11M | 1 | 2011-03-11 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-01-17 | Trius Therapeutics Inc (TSRX) Delisted | Other (J) | −13,883,800 | $0 | EDGAR |
| 2011-03-11 | AMRN | Sell (S) | −3,185,000 | -$23.11M | EDGAR |
| 2010-08-18 | Trius Therapeutics Inc (TSRX) Delisted | Mixed | +14,462,288 | $32.25M | EDGAR |
| 2010-08-10 | Trius Therapeutics Inc (TSRX) Delisted | Mixed | +3,615,572 | $8.06M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.